Literature DB >> 23149414

Vitamin D directly regulates Mdm2 gene expression in osteoblasts.

Hankui Chen1, Grant Reed, Janete Guardia, Sandeep Lakhan, Oliver Couture, Emily Hays, Nalini Chandar.   

Abstract

While Mdm2 is an important negative regulator of the p53 tumor suppressor, it also possesses p53-independent functions in cellular differentiation processes. Mdm2 expression is alternatively regulated by two P1 and P2 promoters. In this study we show that the P2-intiated transcription of Mdm2 gene is activated by 1,25-dihydroxy vitamin D3 in MC3T3 cells. By using P1 and P2-specific reporters, we demonstrate that only the P2-promoter responds to vitamin D treatment. We have further identified a potential vitamin D receptor responsive element proximal to the two p53 response elements within the Mdm2 P2 promoter. Using cell lines that are p53-temperature sensitive and p53-null, we show requirement of p53 for VDR-mediated up regulation of Mdm2 expression. Our results indicate that 1,25-dihydroxy vitamin D3 and its receptor have a role in the regulation of P2-initiated Mdm2 gene expression in a p53-dependent way.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23149414      PMCID: PMC3544976          DOI: 10.1016/j.bbrc.2012.11.003

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  33 in total

1.  Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development.

Authors:  Shunbin Xiong; Carolyn S Van Pelt; Ana C Elizondo-Fraire; Geng Liu; Guillermina Lozano
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

Review 2.  p53-independent activities of MDM2 and their relevance to cancer therapy.

Authors:  Zhuo Zhang; Ruiwen Zhang
Journal:  Curr Cancer Drug Targets       Date:  2005-02       Impact factor: 3.428

3.  Relationship of bone morphogenetic protein expression during osteoblast differentiation to wild type p53.

Authors:  Nalini Chandar; John Swindle; Ann Szajkovics; Kevin Kolman
Journal:  J Orthop Res       Date:  2005-07-01       Impact factor: 3.494

4.  DNA sequences in the rat osteocalcin gene that bind the 1,25-dihydroxyvitamin D3 receptor and confer responsiveness to 1,25-dihydroxyvitamin D3.

Authors:  M B Demay; J M Gerardi; H F DeLuca; H M Kronenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

5.  Tissue-specific differences of p53 inhibition by Mdm2 and Mdm4.

Authors:  Jason D Grier; Shunbin Xiong; Ana C Elizondo-Fraire; John M Parant; Guillermina Lozano
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

6.  A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans.

Authors:  Gareth L Bond; Wenwei Hu; Elisabeth E Bond; Harlan Robins; Stuart G Lutzker; Nicoleta C Arva; Jill Bargonetti; Frank Bartel; Helge Taubert; Peter Wuerl; Kenan Onel; Linwah Yip; Shih-Jen Hwang; Louise C Strong; Guillermina Lozano; Arnold J Levine
Journal:  Cell       Date:  2004-11-24       Impact factor: 41.582

7.  Comparative genome analysis identifies the vitamin D receptor gene as a direct target of p53-mediated transcriptional activation.

Authors:  Reo Maruyama; Fumio Aoki; Minoru Toyota; Yasushi Sasaki; Hirofumi Akashi; Hiroaki Mita; Hiromu Suzuki; Kimishige Akino; Mutsumi Ohe-Toyota; Yumiko Maruyama; Haruyuki Tatsumi; Kohzoh Imai; Yasuhisa Shinomura; Takashi Tokino
Journal:  Cancer Res       Date:  2006-05-01       Impact factor: 12.701

8.  Cloning of the human 1 alpha,25-dihydroxyvitamin D-3 24-hydroxylase gene promoter and identification of two vitamin D-responsive elements.

Authors:  K S Chen; H F DeLuca
Journal:  Biochim Biophys Acta       Date:  1995-07-25

9.  Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor.

Authors:  Anna Saramäki; Claire M Banwell; Moray J Campbell; Carsten Carlberg
Journal:  Nucleic Acids Res       Date:  2006-01-24       Impact factor: 16.971

10.  Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling.

Authors:  Christopher J Lengner; Heather A Steinman; James Gagnon; Thomas W Smith; Janet E Henderson; Barbara E Kream; Gary S Stein; Jane B Lian; Stephen N Jones
Journal:  J Cell Biol       Date:  2006-03-13       Impact factor: 10.539

View more
  8 in total

1.  MDM2 binds and inhibits vitamin D receptor.

Authors:  Kristina Heyne; Tessa-Carina Heil; Birgit Bette; Jörg Reichrath; Klaus Roemer
Journal:  Cell Cycle       Date:  2015-05-13       Impact factor: 4.534

2.  p53 directly activates cystatin D/CST5 to mediate mesenchymal-epithelial transition: a possible link to tumor suppression by vitamin D3.

Authors:  Sabine Hünten; Heiko Hermeking
Journal:  Oncotarget       Date:  2015-06-30

Review 3.  Interaction of vitamin D with membrane-based signaling pathways.

Authors:  María Jesús Larriba; José Manuel González-Sancho; Félix Bonilla; Alberto Muñoz
Journal:  Front Physiol       Date:  2014-02-18       Impact factor: 4.566

4.  Association between the BsmI Polymorphism in the Vitamin D Receptor Gene and Breast Cancer Risk: Results from a Pakistani Case-Control Study.

Authors:  Muhammad Usman Rashid; Merium Muzaffar; Faiz Ali Khan; Maria Kabisch; Noor Muhammad; Sabeen Faiz; Asif Loya; Ute Hamann
Journal:  PLoS One       Date:  2015-10-30       Impact factor: 3.240

5.  P53 regulation of osteoblast differentiation is mediated through specific microRNAs.

Authors:  Shivang Shah; Elisha Pendleton; Oliver Couture; Mustafa Broachwalla; Teresa Kusper; Lauren A C Alt; J Fay Michael; Nalini Chandar
Journal:  Biochem Biophys Rep       Date:  2021-02-01

Review 6.  The vitamin D receptor: a tumor suppressor in skin.

Authors:  Daniel D Bikle
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

Review 7.  Tumor suppression in skin and other tissues via cross-talk between vitamin D- and p53-signaling.

Authors:  Jörg Reichrath; Sandra Reichrath; Kristina Heyne; Thomas Vogt; Klaus Roemer
Journal:  Front Physiol       Date:  2014-06-03       Impact factor: 4.566

8.  20(S)-protopanaxadiol regio-selectively targets androgen receptor: anticancer effects in castration-resistant prostate tumors.

Authors:  Mohamed Ben-Eltriki; Subrata Deb; Mohamed Hassona; Gray Meckling; Ladan Fazli; Mei Yieng Chin; Nada Lallous; Takeshi Yamazaki; William Jia; Paul S Rennie; Artem Cherkasov; Emma S Tomlinson Guns
Journal:  Oncotarget       Date:  2018-04-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.